TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Unimedic Pharma AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
345,575
|
386,076
|
298,436 |
| Financial expenses |
7,094
|
3,847
|
2,016 |
| Earnings before taxes |
30,525
|
74,119
|
63,890 |
| EBITDA |
36,208
|
83,907
|
72,518 |
| Total assets |
203,360
|
202,017
|
188,039 |
| Current assets |
190,913
|
186,801
|
167,244 |
| Current liabilities |
37,521
|
58,254
|
80,421 |
| Equity capital |
96,928
|
76,673
|
34,876 |
| - share capital |
206
|
203
|
189 |
| Employees (average) |
31
|
27
|
27 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.7%
|
38.0%
|
18.5% |
| Turnover per employee |
11,148
|
14,299
|
11,053 |
| Profit as a percentage of turnover |
8.8%
|
19.2%
|
21.4% |
| Return on assets (ROA) |
18.5%
|
38.6%
|
35.0% |
| Current ratio |
508.8%
|
320.7%
|
208.0% |
| Return on equity (ROE) |
31.5%
|
96.7%
|
183.2% |
| Change turnover |
-47,461
|
66,463
|
63,615 |
| Change turnover % |
-12%
|
21%
|
27% |
| Chg. No. of employees |
4
|
0
|
2 |
| Chg. No. of employees % |
15%
|
0%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.